Concurrent Investment Advisors LLC Boosts Position in Healthpeak Properties, Inc. (NYSE:DOC)

Concurrent Investment Advisors LLC lifted its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 10.9% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 11,218 shares of the real estate investment trust’s stock after acquiring an additional 1,101 shares during the period. Concurrent Investment Advisors LLC’s holdings in Healthpeak Properties were worth $227,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of the stock. Steward Partners Investment Advisory LLC raised its holdings in Healthpeak Properties by 22.4% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 5,450 shares of the real estate investment trust’s stock valued at $110,000 after buying an additional 998 shares during the period. Assetmark Inc. raised its holdings in Healthpeak Properties by 433.5% in the 4th quarter. Assetmark Inc. now owns 2,982 shares of the real estate investment trust’s stock valued at $60,000 after buying an additional 2,423 shares during the period. Proficio Capital Partners LLC purchased a new stake in Healthpeak Properties in the 4th quarter valued at about $1,086,000. Raymond James Financial Inc. purchased a new stake in Healthpeak Properties in the 4th quarter valued at about $22,545,000. Finally, Moors & Cabot Inc. raised its holdings in Healthpeak Properties by 8.4% in the 4th quarter. Moors & Cabot Inc. now owns 27,093 shares of the real estate investment trust’s stock valued at $549,000 after buying an additional 2,101 shares during the period. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Stock Performance

Shares of Healthpeak Properties stock opened at $18.44 on Friday. Healthpeak Properties, Inc. has a one year low of $16.64 and a one year high of $23.26. The company has a market cap of $12.81 billion, a PE ratio of 46.10, a P/E/G ratio of 2.10 and a beta of 1.03. The company has a debt-to-equity ratio of 1.01, a quick ratio of 1.35 and a current ratio of 1.35. The business has a 50-day simple moving average of $17.47 and a 200-day simple moving average of $18.96.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings data on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, hitting analysts’ consensus estimates of $0.46. Healthpeak Properties had a return on equity of 3.06% and a net margin of 9.99%. The business had revenue of $702.89 million during the quarter, compared to the consensus estimate of $690.76 million. During the same period in the previous year, the company posted $0.45 earnings per share. The business’s revenue for the quarter was up 15.9% on a year-over-year basis. On average, equities research analysts forecast that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The business also recently disclosed a monthly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Friday, September 19th will be given a dividend of $0.1017 per share. This represents a $1.22 dividend on an annualized basis and a dividend yield of 6.62%. The ex-dividend date is Friday, September 19th. Healthpeak Properties’s dividend payout ratio is presently 305.00%.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on DOC shares. Argus restated a “buy” rating and issued a $25.00 price objective on shares of Healthpeak Properties in a report on Tuesday, April 29th. Wall Street Zen lowered shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Monday, July 7th. Evercore ISI reduced their price objective on shares of Healthpeak Properties from $23.00 to $21.00 and set an “outperform” rating on the stock in a report on Monday, April 28th. Wells Fargo & Company cut their price target on shares of Healthpeak Properties from $22.00 to $20.00 and set an “equal weight” rating on the stock in a research note on Monday, June 2nd. Finally, Scotiabank cut their price target on shares of Healthpeak Properties from $23.00 to $21.00 and set a “sector outperform” rating on the stock in a research note on Monday, May 12th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $23.27.

Insider Transactions at Healthpeak Properties

In other Healthpeak Properties news, Director Tommy G. Thompson purchased 5,777 shares of the stock in a transaction that occurred on Wednesday, May 28th. The stock was purchased at an average cost of $17.27 per share, with a total value of $99,768.79. Following the completion of the acquisition, the director directly owned 144,290 shares of the company’s stock, valued at $2,491,888.30. This trade represents a 4.17% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Scott M. Brinker purchased 11,337 shares of the stock in a transaction that occurred on Monday, April 28th. The stock was acquired at an average cost of $17.68 per share, with a total value of $200,438.16. Following the completion of the acquisition, the chief executive officer directly owned 201,863 shares of the company’s stock, valued at $3,568,937.84. This represents a 5.95% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders purchased 29,764 shares of company stock valued at $521,909. 0.23% of the stock is currently owned by corporate insiders.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.